PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsStem cell lines show high genetic variation, study finds

BioNews

Stem cell lines show high genetic variation, study finds

Published 27 September 2012 posted in News and appears in BioNews 591

Author

Julianna Photopoulos

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.

An international team of researchers have found that both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) show higher genetic abnormalities than other cells....

An international team of researchers has found that both embryonic stem cells (ESCs) and iPS (induced pluripotent stem) cells show higher genetic abnormalities than other cells.

The study, led by stem cell scientists from the University of California, San Diego School of Medicine and The Scripps Research Institute, used a high-resolution molecular technique called SNP (single nucleotide polymorphism) analysis to look for genetic changes at more than a million sites in the human genome.

'We found that human pluripotent cells (hESCs and iPS cells) had higher frequencies of genomic aberrations than other cell types', said lead author Dr Louise Laurent, assistant professor in the UCSD Department of Reproductive Medicine.

'Most strikingly, we observed a higher frequency of genomic duplications in hESCs and deletions in iPS cells, when compared to non-pluripotent samples', she added.

The scientists also identified specific regions in the genome where the abnormalities were more likely to arise. In ESCs, the duplications were near pluripotency-associated genes (genes that allow the cells to turn into any other kind of cell in the body). In iPS cells, duplications involved cell proliferation genes, and deletions involved tumor suppressor genes.

Dr Laurent said: 'We were surprised to see profound genetic changes occurring in some cultures over very short periods of time, such as during the process of reprogramming somatic cells into iPS cells and during differentiation of the cells in culture'.

The ability of pluripotent stem cells to change into other cell types has made them a potential source for cell replacement therapies, but abnormalities like these can push cells towards becoming cancerous and therefore limiting their suitability as therapeutic agents.

'Since genetic aberrations are often associated with cancers, it is vital that cell lines destined for clinical use are free from cancer-associated genomic alterations', explained author Dr Jeanne Loring, Director of the Center for Regenerative Medicine at The Scripps Research Institute.

These changes could not have been detected by traditional microscopic techniques, such as karyotyping, due to the fact that they occur very rapidly. In the past, SNP analysis was not a part of routine monitoring of hESC and iPS cells cultures, but these results suggest that perhaps it should be in order to assure the cells' stability and clinical safety.

'We don't know yet what effects, if any, these genetic abnormalities will have on the outcome of basic research studies or clinical applications, and we need to find out', Dr Laurent said.

She added: 'The results of the study illustrate the need for frequent genomic monitoring of pluripotent stem cell cultures'.

The study was published in the journal Cell Stem Cell.

Related Articles

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
1 November 2012 • 2 minutes read

Stem cell setback: Reprogrammed stem cells may induce immune response

by Dr Rebecca Robey

IPS (induced pluripotent stem) cells from mice can be recognised by their own immune system and destroyed, scientists at the University of California, San Diego, have found...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
4 October 2012 • 1 minute read

Study finds abnormalities in iPS Cells

by Leo Perfect

Adult human cells maintain a 'memory' when reprogrammed into a stem cell-like state, US scientists have found. The finding suggests the resulting induced pluripotent stem (iPS) cells are not yet a viable alternative to human embryonic stem (ES) cells for modelling or treating disease...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
26 September 2012 • 2 minutes read

Faulty stem cells may cause male pattern baldness

by Dr Rachael Panizzo

Faulty stem cells may cause the onset of male pattern baldness, scientists have found. Professor George Cotsarelis and colleagues at the University of Pennsylvania School of Medicine in Philadelphia discovered that stem cells are present in the hair follicles of both bald and hairy scalp regions in men with male pattern baldness...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
13 September 2010 • 2 minutes read

US stem cell research potentially back on track

by Dr Antony Starza-Allen

A federal appeals court in the US has ruled that federal funding for embryonic stem cell research may continue and an injunction placed on the funding by a lower court last month is temporarily suspended...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
30 April 2010 • 2 minutes read

Key US stem cell lines returned to use

by Dr Nadeem Shaikh

US-based scientists working on embryonic stem cell (ES cell) research are relieved that the most important cell lines in their field have been approved for research by new government guidelines. During the Bush administration, US government funding for research involving ES cells was restricted to just 20 cell lines, all of which were in existence before 9 August 2001...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
16 April 2010 • 1 minute read

US stem cell funding 'extraordinarily close'

by Nishat Hyder

Over a year since US President Barack Obama announced his decision to allow federal funding for embryonic stem cell research, the widely utilised cell lines, H9 and H7, are still weeks away from receiving federal funding approval. The H9 and H7 cell lines were derived and approved under the Bush administration and are currently owned by WiCell Research Institute in Madison, Wisconsin. However, for months now the fate of these two much used lines has been uncertain. According to...

Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
CC BY 4.0
Image by K Hardy via the Wellcome Collection. Depicts a human embryo at the blastocyst stage (about six days after fertilisation) 'hatching' out of the zona pellucida.
News
1 April 2010 • 2 minutes read

DNA difference between stem cell types found

by Dr Rachael Panizzo

Researchers at the Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine have pinpointed key genetic differences between mouse embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells)....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Faulty stem cells may cause male pattern baldness

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856